Abstract:Background: Identifying drug-binding targets and their corresponding sites is crucial for drug discovery and mechanism studies. Limited proteolysis-coupled mass spectrometry (LiP-MS) is a sophisticated method used for the detection of compound and protein interactions. However, in some cases, LiP-MS cannot identify the target proteins due to the small structure changes or the lack of enrichment of low-abundant protein. To overcome this drawback, we developed a thermostability-assisted limited proteolysis-coupled mass spectrometry (TALiP-MS) approach for efficient drug target discovery. Results: We proved that the novel strategy, TALiP-MS, could efficiently identify target proteins of various ligands, including cyclosporin A (a calcineurin inhibitor), geldanamycin (an HSP90 inhibitor), and staurosporine (a kinase inhibitor), with accurately recognizing drug-binding domains. The TALiP protocol increased the number of target peptides detected in LiP-MS experiments by 2- to 8-fold. Meanwhile, the TALiP-MS approach can not only identify both ligand-binding stability and destabilization proteins but also shows high complementarity with the thermal proteome profiling (TPP) and machine learning-based limited proteolysis (LiP-Quant) methods. The developed TALiP-MS approach was applied to identify the target proteins of celastrol (CEL), a natural product known for its strong antioxidant and anti-cancer angiogenesis effect. Among them, four proteins, MTHFD1, UBA1, ACLY, and SND1 were further validated for their strong affinity to CEL by using cellular thermal shift assay. Additionally, the destabilized proteins induced by CEL such as TAGLN2 and CFL1 were also validated. Significance: Collectively, these findings underscore the efficacy of the TALiP-MS method for identifying drug targets, elucidating binding sites, and even detecting drug-induced conformational changes in target proteins in complex proteomes.

A computational method for detection of ligand-binding proteins from dose range thermal proteome profiles

Computational analysis of ligand dose range thermal proteome profiles

Precipitate-Supported Thermal Proteome Profiling Coupled with Deep Learning for Comprehensive Screening of Drug Target Proteins

A Cellular Thermal Shift Assay for Detecting Amino Acid Sites Involved in Drug Target Engagement

Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays

Identifying drug targets in tissues and whole blood with thermal-shift profiling

Thermostability-assisted limited proteolysis-coupled mass spectrometry for capturing drug target proteins and sites

An Integrated Structure- and System-Based Framework to Identify New Targets of Metabolites and Known Drugs

Determining the In Vitro Ligand-Target Interaction by Cellular Thermal Shift Assay and Isothermal Dose-Response Fingerprint Assay

Tracking cancer drugs in living cells by thermal profiling of the proteome

Highly Effective Identification of Drug Targets at the Proteome Level by Ph-Dependent Protein Precipitation

Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivo

Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane

MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput

Protein-ligand binding site detection as an alternative route to molecular docking and drug repurposing

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Sensitive Measurement of Drug-Target Engagement by a Cellular Thermal Shift Assay with Multiplex Proximity Extension Readout

Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation

An immuno-chemo-proteomics method for drug target deconvolution

An Automatable Analytical Algorithm for Structure-Based Protein Functional Annotation via Detection of Specific Ligand 3D Binding Sites: Application to ATP (ser/thr Protein Kinases) and GTP (Small Ras-type G-Proteins) Binding Sites